Your browser doesn't support javascript.
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
Parker, Edward P K; Desai, Shalini; Marti, Melanie; Nohynek, Hanna; Kaslow, David C; Kochhar, Sonali; O'Brien, Katherine L; Hombach, Joachim; Wilder-Smith, Annelies.
  • Parker EPK; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland; The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: edward.parker@lshtm.ac.uk.
  • Desai S; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Marti M; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Nohynek H; Department of Health Security at the Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Kaslow DC; PATH Essential Medicines, PATH, Seattle, Washington, USA.
  • Kochhar S; Global Healthcare Consulting, New Delhi, India; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • O'Brien KL; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Hombach J; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Wilder-Smith A; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland; Institute of Social and Preventive Medicine, University of Berne, Berne, Switzerland; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Lancet Glob Health ; 10(3): e326-e328, 2022 03.
Article in English | MEDLINE | ID: covidwho-1683797

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Vaccines / COVID-19 Type of study: Reviews Topics: Vaccines Limits: Humans Language: English Journal: Lancet Glob Health Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Vaccines / COVID-19 Type of study: Reviews Topics: Vaccines Limits: Humans Language: English Journal: Lancet Glob Health Year: 2022 Document Type: Article